<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font6" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font7" size="10" family="Giovanni,Bold" color="#000000"/>
	<fontspec id="font8" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font9" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font10" size="10" family="GillSans,Italic" color="#ffffff"/>
	<fontspec id="font11" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font12" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font13" size="10" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font14" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font15" size="9" family="UZDGDA+Times,Bold" color="#000000"/>
	<fontspec id="font16" size="9" family="SymbolMT" color="#000000"/>
	<fontspec id="font17" size="11" family="UZDGDA+Times,Bold" color="#000000"/>
	<fontspec id="font18" size="8" family="UZDGDA+Times,Bold" color="#000000"/>
	<fontspec id="font19" size="8" family="UZDGDA+Times,Bold" color="#000000"/>
	<fontspec id="font20" size="8" family="SymbolMT" color="#000000"/>
	<fontspec id="font21" size="8" family="SymbolMT" color="#000000"/>
<text top="41" left="55" width="116" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">BMC Immunology 2005, 6 :22<i>BMC Immunology</i></text>
<text top="41" left="368" width="186" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.biomedcentral.com/1471-2172/6/22</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="130" segment_no="11" tag_type="text">Page 4 of 9<b>6</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="131" segment_no="12" tag_type="text">(page number not for citation purposes)</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="72" segment_no="10" tag_type="text">0.02 vs 0.1 ± 0.03, p &lt; 0.003) and cyclin E (0.46 ± 0.03 vs</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="73" segment_no="10" tag_type="text">0.1 ± 0.04, p &lt; 0.007). These results (Figure 2B) obtained</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="74" segment_no="10" tag_type="text">from a semi-quantitative PCR analysis demonstrate that<i>(page number not for citation purposes)</i></text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="75" segment_no="10" tag_type="text">the aberrant alloimmune activation responsible for graft</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="76" segment_no="10" tag_type="text">rejection is associated with the increased expression of<a href="">lts (Figure 2B</a>) obtained</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t10" reading_order_no="77" segment_no="2" tag_type="text">cyclins. More significantly, CsA treatment significantly</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t11" reading_order_no="78" segment_no="2" tag_type="text">decreased mRNA expression of cyclins, alloimmune acti-</text>
<text top="110" left="313" width="174" height="9" font="font4" id="p1_t12" reading_order_no="79" segment_no="2" tag_type="text">vation and prolongation of graft survival.</text>
<text top="134" left="313" width="201" height="9" font="font5" id="p1_t13" reading_order_no="80" segment_no="4" tag_type="title">Correlation of the expression of cyclins and pro-</text>
<text top="146" left="313" width="163" height="9" font="font5" id="p1_t14" reading_order_no="81" segment_no="4" tag_type="title">inflammatory cytokines in allo-immune</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t15" reading_order_no="82" segment_no="5" tag_type="text">To confirm that the increased expression of cyclins in lym-</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t16" reading_order_no="83" segment_no="5" tag_type="text">phocytes from rejecting rats was due to alloimmune acti-<i><b>Correlation of the expression of cyclins and pro-</b></i></text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t17" reading_order_no="84" segment_no="5" tag_type="text">vation, we performed mixed lymphocyte reaction (MLR)<i><b>inflammatory cytokines in allo-immune</b></i></text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t18" reading_order_no="85" segment_no="5" tag_type="text">using spleen cells from donor animals (WF) as stimulators</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t19" reading_order_no="86" segment_no="5" tag_type="text">and splenocytes from recipients (LEW) as responders.</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t20" reading_order_no="87" segment_no="5" tag_type="text">Three groups were studied; isografts (control), untreated</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t21" reading_order_no="88" segment_no="5" tag_type="text">allografts (A), and CsA-treated allografts (B). After five-</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t22" reading_order_no="89" segment_no="5" tag_type="text">day MLR lymphocytes were harvested and washed. RNA</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t23" reading_order_no="90" segment_no="5" tag_type="text">was prepared; reverse transcribed to cDNA, and was</text>
<text top="261" left="313" width="241" height="13" font="font4" id="p1_t24" reading_order_no="91" segment_no="5" tag_type="text">amplified by RT-PCR for cyclin D3, IFN- γ , TNF- α , IL-6 and</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t25" reading_order_no="92" segment_no="5" tag_type="text">IL-10 mRNA. As shown in the Figure 2C the mRNA</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t26" reading_order_no="93" segment_no="5" tag_type="text">expression of cyclin D3 was higher in lymphocytes from</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t27" reading_order_no="94" segment_no="5" tag_type="text">untreated allografts group A as compared to lymphocytes</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t28" reading_order_no="95" segment_no="5" tag_type="text">from isografts group B . This increased expression of cyclin</text>
<text top="319" left="313" width="241" height="13" font="font4" id="p1_t29" reading_order_no="96" segment_no="5" tag_type="text">D3 correlated with the pro-inflammatory cytokines IFN- γ</text>
<text top="331" left="313" width="241" height="13" font="font4" id="p1_t30" reading_order_no="97" segment_no="5" tag_type="text">and TNF- α mRNA expression. The expression of IL-6 and</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t31" reading_order_no="98" segment_no="5" tag_type="text">IL-10 mRNA was not statistically significant between</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t32" reading_order_no="99" segment_no="5" tag_type="text">groups A and B. CsA treatment decreased cyclin D3<a href="">2C th</a>e mRNA</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="100" segment_no="5" tag_type="text">expression by 50% and inhibited statistically significant</text>
<text top="378" left="313" width="241" height="13" font="font4" id="p1_t34" reading_order_no="101" segment_no="5" tag_type="text">(p &lt; 0.03) IFN- γ mRNA expression. Lymphocyte activa-</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t35" reading_order_no="102" segment_no="5" tag_type="text">tion in MLR assay was quantified by 3 H-thymidine uptake<b>group A </b></text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t36" reading_order_no="103" segment_no="5" tag_type="text">assay. Proliferation of lymphocytes from untreated allo-</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t37" reading_order_no="104" segment_no="5" tag_type="text">grafts was significantly higher (two tailed p value = 0.02)</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t38" reading_order_no="105" segment_no="5" tag_type="text">compared to CsA- treated allografts (Mean ± SEM of<b>group B</b></text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="106" segment_no="5" tag_type="text">counts per minute, n = 3, 11796 ± 728 vs 7575 ± 360).</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t40" reading_order_no="107" segment_no="5" tag_type="text">These results support our conclusions from rat transplant</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t41" reading_order_no="108" segment_no="5" tag_type="text">studies that the alloimmune results in increased expres-</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="109" segment_no="5" tag_type="text">sion of cyclins mRNA that correlates with production of</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t43" reading_order_no="110" segment_no="5" tag_type="text">pro-inflammatory cytokines. Allo-immune activation is</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="111" segment_no="5" tag_type="text">demonstrated by increased lymphocyte proliferation from</text>
<text top="510" left="313" width="218" height="9" font="font4" id="p1_t45" reading_order_no="112" segment_no="5" tag_type="text">MLR assay, which decreased in CsA treated animals.</text>
<text top="533" left="313" width="241" height="9" font="font5" id="p1_t46" reading_order_no="113" segment_no="8" tag_type="title">p21WAF1/CIP1 over-expression, lymphocyte proliferation</text>
<text top="545" left="313" width="81" height="9" font="font5" id="p1_t47" reading_order_no="114" segment_no="8" tag_type="title">and IL-2 expression</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="115" segment_no="9" tag_type="text">To confirm our previous in vitro and in vivo studies that</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="116" segment_no="9" tag_type="text">p21WAF1/CIP1 over-expression will inhibit lymphocyte</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="117" segment_no="9" tag_type="text">proliferation and IL-2 expression, we conducted studies</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="118" segment_no="9" tag_type="text">using Jurkat T cells. Jurkat T cells were transfected with</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="119" segment_no="9" tag_type="text">empty vector plasmid DNA (control DNA) and</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="120" segment_no="9" tag_type="text">p21WAF1/CIP1 sense plasmid DNA. We used Jurkat T</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="121" segment_no="9" tag_type="text">cells for these experiments because of the ease with which</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="122" segment_no="9" tag_type="text">these cells can be transfected as compared to primary T</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="123" segment_no="9" tag_type="text">cells; these p21WAF1/CIP1 over-expressing Jurkat T cells</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="124" segment_no="9" tag_type="text">are described previously [7]. No differences were observed</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="125" segment_no="9" tag_type="text">in the proliferation of normal Jurkat cells and Jurkat cells</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="126" segment_no="9" tag_type="text">transfected with empty vector DNA. Control and</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="127" segment_no="9" tag_type="text">p21WAF1/CIP1 over-expressing Jurkat T cells were acti-</text>
<text top="707" left="313" width="241" height="13" font="font4" id="p1_t61" reading_order_no="128" segment_no="9" tag_type="text">vated with PHA (2 µ g/ml) for 4 h for IL-2 mRNA expres-</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="129" segment_no="9" tag_type="text">sion studies and 24 h for proliferation studies using 3 [H]-</text>
<text top="444" left="55" width="228" height="9" font="font10" id="p1_t63" reading_order_no="53" segment_no="6" tag_type="title">In vitro and in vivo mRNA expression of Cyclins relates to</text>
<text top="444" left="55" width="86" height="9" font="font11" id="p1_t64" reading_order_no="55" segment_no="6" tag_type="title">alloimmune activation<i><b>p21WAF1/CIP1 over-expression, lymphocyte proliferation </b></i></text>
<text top="444" left="55" width="37" height="9" font="font12" id="p1_t65" reading_order_no="54" segment_no="6" tag_type="title">Figure 2<i><b>and IL-2 expression</b></i></text>
<text top="455" left="55" width="215" height="9" font="font13" id="p1_t66" reading_order_no="56" segment_no="7" tag_type="text">In vitro and in vivo mRNA expression of Cyclins</text>
<text top="466" left="55" width="240" height="9" font="font12" id="p1_t67" reading_order_no="57" segment_no="7" tag_type="text">relates to alloimmune activation : A: Cyclins; D3, E and<i>in vitro </i></text>
<text top="474" left="55" width="227" height="13" font="font14" id="p1_t68" reading_order_no="58" segment_no="7" tag_type="text">G and β -actin mRNA expression in lymphocytes isolated</text>
<text top="487" left="55" width="230" height="9" font="font14" id="p1_t69" reading_order_no="59" segment_no="7" tag_type="text">from spleens of rat heart transplant recipients. Untreated<i>in vivo </i></text>
<text top="498" left="55" width="239" height="9" font="font14" id="p1_t70" reading_order_no="60" segment_no="7" tag_type="text">(lanes 4,5), CsA treated (lanes 1,2,3). B: Mean ± SEM of the</text>
<text top="506" left="55" width="229" height="13" font="font14" id="p1_t71" reading_order_no="61" segment_no="7" tag_type="text">ratio cyclins with β -actin, p values are calculated between</text>
<text top="520" left="55" width="237" height="9" font="font14" id="p1_t72" reading_order_no="62" segment_no="7" tag_type="text">densitometric numbers of untreated and CsA treated trans-</text>
<text top="530" left="55" width="241" height="9" font="font14" id="p1_t73" reading_order_no="63" segment_no="7" tag_type="text">plant recipient. C: Cyclin D3 and pro-inflammatory cytokines</text>
<text top="541" left="55" width="241" height="9" font="font14" id="p1_t74" reading_order_no="64" segment_no="7" tag_type="text">mRNA expression in lymphocyte from MLR assay using stim-</text>
<text top="552" left="55" width="240" height="9" font="font14" id="p1_t75" reading_order_no="65" segment_no="7" tag_type="text">ulants from donor strain with responders from donor strain</text>
<text top="563" left="55" width="234" height="9" font="font14" id="p1_t76" reading_order_no="66" segment_no="7" tag_type="text">(Control) untreated rejecting transplant recipients (A) and</text>
<text top="573" left="55" width="231" height="9" font="font14" id="p1_t77" reading_order_no="67" segment_no="7" tag_type="text">CsA treated non rejecting transplant recipients (B). The p</text>
<text top="584" left="55" width="237" height="9" font="font14" id="p1_t78" reading_order_no="68" segment_no="7" tag_type="text">values represent the statistical significance between ratio of</text>
<text top="592" left="55" width="222" height="13" font="font14" id="p1_t79" reading_order_no="69" segment_no="7" tag_type="text">densitometric numbers for each gene with β -actin from<a href="">d previously [7</a>]. No differences were observed</text>
<text top="606" left="55" width="241" height="9" font="font14" id="p1_t80" reading_order_no="70" segment_no="7" tag_type="text">untreated ( Group A ) vs CsA ( Group B ) treated transplant</text>
<text top="616" left="55" width="41" height="9" font="font14" id="p1_t81" reading_order_no="71" segment_no="7" tag_type="text">recipients.</text>
<text top="108" left="93" width="30" height="9" font="font15" id="p1_t82" reading_order_no="3" segment_no="3" tag_type="figure">1 2 3</text>
<text top="108" left="134" width="16" height="9" font="font15" id="p1_t83" reading_order_no="4" segment_no="3" tag_type="figure">4 5</text>
<text top="121" left="102" width="34" height="9" font="font15" id="p1_t84" reading_order_no="5" segment_no="3" tag_type="figure">Cyclin D3</text>
<text top="121" left="166" width="30" height="9" font="font15" id="p1_t85" reading_order_no="7" segment_no="3" tag_type="figure">Cyclin E</text>
<text top="121" left="242" width="31" height="9" font="font15" id="p1_t86" reading_order_no="9" segment_no="3" tag_type="figure">Cyclin G</text>
<text top="108" left="162" width="55" height="9" font="font15" id="p1_t87" reading_order_no="6" segment_no="3" tag_type="figure">1 2 3 4 5</text>
<text top="108" left="241" width="49" height="9" font="font15" id="p1_t88" reading_order_no="8" segment_no="3" tag_type="figure">1 2 3 4 5</text>
<text top="155" left="168" width="55" height="9" font="font15" id="p1_t89" reading_order_no="10" segment_no="3" tag_type="figure">1 2 3 4 5<i>In vitro </i></text>
<text top="163" left="185" width="24" height="12" font="font16" id="p1_t90" reading_order_no="11" segment_no="3" tag_type="figure">ββββ -actin</text>
<text top="117" left="58" width="8" height="11" font="font17" id="p1_t91" reading_order_no="2" segment_no="3" tag_type="figure">A<i>in vivo </i></text>
<text top="175" left="58" width="7" height="11" font="font17" id="p1_t92" reading_order_no="12" segment_no="3" tag_type="figure">B</text>
<text top="271" left="127" width="4" height="9" font="font18" id="p1_t93" reading_order_no="23" segment_no="3" tag_type="figure">0</text>
<text top="256" left="122" width="9" height="9" font="font18" id="p1_t94" reading_order_no="22" segment_no="3" tag_type="figure">0.1<b>Figure 2</b></text>
<text top="243" left="122" width="9" height="9" font="font18" id="p1_t95" reading_order_no="21" segment_no="3" tag_type="figure">0.2<i><b>In vitro </b></i></text>
<text top="229" left="122" width="9" height="9" font="font18" id="p1_t96" reading_order_no="20" segment_no="3" tag_type="figure">0.3<b>and </b></text>
<text top="215" left="122" width="9" height="9" font="font18" id="p1_t97" reading_order_no="19" segment_no="3" tag_type="figure">0.4<i><b>in vivo </b></i></text>
<text top="201" left="122" width="9" height="9" font="font18" id="p1_t98" reading_order_no="18" segment_no="3" tag_type="figure">0.5<b>mRNA expression of Cyclins </b></text>
<text top="187" left="122" width="9" height="9" font="font18" id="p1_t99" reading_order_no="17" segment_no="3" tag_type="figure">0.6<b>relates to alloimmune activation</b></text>
<text top="282" left="136" width="98" height="9" font="font18" id="p1_t100" reading_order_no="24" segment_no="3" tag_type="figure">Cyclin D3 Cyclin E Cyclin G</text>
<text top="256" left="117" width="0" height="9" font="font19" id="p1_t101" reading_order_no="16" segment_no="3" tag_type="figure">Gene<b>A: </b></text>
<text top="231" left="117" width="0" height="16" font="font19" id="p1_t102" reading_order_no="15" segment_no="3" tag_type="figure">-act ββββ /</text>
<text top="217" left="117" width="0" height="9" font="font19" id="p1_t103" reading_order_no="14" segment_no="3" tag_type="figure">in</text>
<text top="209" left="117" width="0" height="9" font="font19" id="p1_t104" reading_order_no="13" segment_no="3" tag_type="figure">ratio</text>
<text top="223" left="250" width="40" height="9" font="font18" id="p1_t105" reading_order_no="27" segment_no="3" tag_type="figure">CsA Treated</text>
<text top="235" left="250" width="32" height="9" font="font18" id="p1_t106" reading_order_no="28" segment_no="3" tag_type="figure">Untreated</text>
<text top="204" left="154" width="21" height="9" font="font18" id="p1_t107" reading_order_no="25" segment_no="3" tag_type="figure">p&lt;0.03</text>
<text top="194" left="174" width="56" height="9" font="font18" id="p1_t108" reading_order_no="26" segment_no="3" tag_type="figure">p&lt;0.007 p&lt;0.003<b>B: </b></text>
<text top="392" left="131" width="4" height="9" font="font18" id="p1_t109" reading_order_no="43" segment_no="3" tag_type="figure">0</text>
<text top="381" left="126" width="10" height="9" font="font18" id="p1_t110" reading_order_no="42" segment_no="3" tag_type="figure">0.2</text>
<text top="369" left="126" width="10" height="9" font="font18" id="p1_t111" reading_order_no="41" segment_no="3" tag_type="figure">0.4</text>
<text top="358" left="126" width="10" height="9" font="font18" id="p1_t112" reading_order_no="40" segment_no="3" tag_type="figure">0.6</text>
<text top="347" left="126" width="10" height="9" font="font18" id="p1_t113" reading_order_no="39" segment_no="3" tag_type="figure">0.8</text>
<text top="335" left="131" width="4" height="9" font="font18" id="p1_t114" reading_order_no="38" segment_no="3" tag_type="figure">1</text>
<text top="324" left="126" width="10" height="9" font="font18" id="p1_t115" reading_order_no="37" segment_no="3" tag_type="figure">1.2<b>C: </b></text>
<text top="312" left="126" width="10" height="9" font="font18" id="p1_t116" reading_order_no="36" segment_no="3" tag_type="figure">1.4</text>
<text top="301" left="126" width="10" height="9" font="font18" id="p1_t117" reading_order_no="35" segment_no="3" tag_type="figure">1.6</text>
<text top="406" left="142" width="21" height="9" font="font18" id="p1_t118" reading_order_no="44" segment_no="3" tag_type="figure">Cyclin</text>
<text top="419" left="147" width="9" height="9" font="font18" id="p1_t119" reading_order_no="45" segment_no="3" tag_type="figure">D3</text>
<text top="404" left="167" width="86" height="12" font="font18" id="p1_t120" reading_order_no="46" segment_no="3" tag_type="figure">IFN- γγγγ TNF- αα α α IL-6 IL-10</text>
<text top="378" left="121" width="0" height="9" font="font19" id="p1_t121" reading_order_no="34" segment_no="3" tag_type="figure">Ge</text>
<text top="368" left="121" width="0" height="9" font="font19" id="p1_t122" reading_order_no="33" segment_no="3" tag_type="figure">ne/</text>
<text top="350" left="121" width="0" height="14" font="font20" id="p1_t123" reading_order_no="32" segment_no="3" tag_type="figure">-actin ββββ</text>
<text top="328" left="121" width="0" height="9" font="font19" id="p1_t124" reading_order_no="31" segment_no="3" tag_type="figure">ra</text>
<text top="320" left="121" width="0" height="9" font="font19" id="p1_t125" reading_order_no="30" segment_no="3" tag_type="figure">tio</text>
<text top="333" left="266" width="24" height="9" font="font18" id="p1_t126" reading_order_no="50" segment_no="3" tag_type="figure">Control<b>Group A</b></text>
<text top="347" left="266" width="6" height="9" font="font18" id="p1_t127" reading_order_no="51" segment_no="3" tag_type="figure">A</text>
<text top="361" left="266" width="5" height="9" font="font18" id="p1_t128" reading_order_no="52" segment_no="3" tag_type="figure">B<b>Group B</b></text>
<text top="332" left="143" width="21" height="9" font="font18" id="p1_t129" reading_order_no="47" segment_no="3" tag_type="figure">p&lt;0.01</text>
<text top="332" left="179" width="21" height="9" font="font18" id="p1_t130" reading_order_no="48" segment_no="3" tag_type="figure">p&lt;0.05</text>
<text top="359" left="203" width="21" height="9" font="font18" id="p1_t131" reading_order_no="49" segment_no="3" tag_type="figure">p&lt;0.05<b>1 2 3</b></text>
<text top="326" left="59" width="8" height="11" font="font17" id="p1_t132" reading_order_no="29" segment_no="3" tag_type="figure">C<b>4 5</b></text>
</page>
</pdf2xml>
